Activity Provided By:

Jointly provided by Purdue University College of Pharmacy, RedMedEd, and the Multiple Myeloma Research Foundation.

Oral Therapy for Outpatient Management of Multiple Myeloma: Options for the COVID-19 Era

Overview / Abstract:	Oncology health care providers (HCPs) who manage patients with multiple myeloma (MM) face new challenges during the COVID-19 pandemic—in particular, the need to balance the risk of delaying or altering MM therapy against the risk of disease progression in a patient population that is practicing social distancing and is at high risk of complications (or worse) from COVID-19. Successfully confronting these challenges will require oncology HCPs to adjust some practice strategies (eg, relying on telemedicine visits; altering treatment choices to minimize patients’ COVID-19 exposure risk while keeping their MM in remission). Ultimately, to be able to achieve the best possible outcomes, oncology HCPs require new, adaptable, responsive guidance to individualizing MM treatment. In this webcast, a panel of renowned clinical MM experts provides timely support and guidance to oncology HCPs on how to respond to the needs of MM patients in the current COVID-19 public health emergency.
Expiration	Oct 15, 2021
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online, Webinar / Webcast / Video
Credits / Hours	Purdue University College of Pharmacy designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity is approved for 1.0 Nursing Contact Hour.
Accreditation	ACCME, ANCC
Presenters / Authors / Faculty	Rachid Baz, MD Senior Member, Myeloma Section Head, Department of Malignant Hematology H. Lee Moffitt Cancer Center and Research Institute Professor of Medicine and Oncologic Sciences University of South Florida Tampa, Florida Ajai Chari, MD Professor of Medicine Director of Clinical Research, Multiple Myeloma Program Icahn School of Medicine at Mount Sinai New York, New York Hearn J. Cho, MD, PhD Associate Professor Icahn School of Medicine at Mount Sinai New York, New York Chief Medical Officer Multiple Myeloma Research Foundation Norwalk, Connecticut Joshua Richter, MD Assistant Professor of Medicine Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai Director of Myeloma Blavatnik Family – Chelsea Medical Center at Mount Sinai New York, New York Raji Vij, MD Professor of Medicine Washington University St. Louis, Missouri
Activity Specialities / Related Topics	Hematology, Oncology / Cancer / Radiation Therapy
Sponsors / Supporters / Grant Providers	This activity is supported by educational grants from Bristol Myers Squibb; Karyopharm Therapeutics, Inc.; and Secura Bio.
Keywords / Search Terms	RedMedEd Web-based, Technology, Online, Virtual, Interactive, CME, Free, Free CE, Free CME, MMRF, RedMedEd, multiple myeloma, hematology/oncology, oncology, hematology, COVID, oral therapy Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map